2018 加拿大临床实践指南:阿片类药物使用障碍的管理

2018-03-05 加拿大健康研究院 CMAJ. 2018 Mar 5;190(9):E247-E257.

阿片类药物使用障碍通常是一种慢性、复发的疾病状态。其发病率和死亡率逐渐增加。然而,随着适当的治疗和随访,个人可以达到持续长期的缓解。本文主要针对阿片类药物使用障碍的临床管理提出指导建议,内容涉及一线和二线治疗方案,替代治疗以及辅助治疗方案,降低危害策略。

中文标题:

2018 加拿大临床实践指南:阿片类药物使用障碍的管理

英文标题:

Management of opioid use disorders: a national clinical practice guideline.

发布机构:

加拿大健康研究院

发布日期:

2018-03-05

简要介绍:

阿片类药物使用障碍通常是一种慢性、复发的疾病状态。其发病率和死亡率逐渐增加。然而,随着适当的治疗和随访,个人可以达到持续长期的缓解。本文主要针对阿片类药物使用障碍的临床管理提出指导建议,内容涉及一线和二线治疗方案,替代治疗以及辅助治疗方案,降低危害策略。

 

拓展指南:阿片相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 加拿大临床实践指南:阿片类药物使用障碍的管理)] GetToolGuiderByIdResponse(projectId=1, id=4b0e81c001566398, title=2018 加拿大临床实践指南:阿片类药物使用障碍的管理, enTitle=Management of opioid use disorders: a national clinical practice guideline., guiderFrom=CMAJ. 2018 Mar 5;190(9):E247-E257., authorId=null, author=, summary=阿片类药物使用障碍通常是一种慢性、复发的疾病状态。其发病率和死亡率逐渐增加。然而,随着适当的治疗和随访,个人可以达到持续长期的缓解。本文主要针对阿片类药物使用障碍的临床管理提出指导建议,内容涉及一线和二线治疗方案,替代治疗以及辅助治疗方案,降低危害策略。 , cover=, journalId=null, articlesId=null, associationId=1611, associationName=加拿大健康研究院, associationIntro=, copyright=0, guiderPublishedTime=Mon Mar 05 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>阿片类药物使用障碍通常是一种慢性、复发的疾病状态。其发病率和死亡率逐渐增加。然而,随着适当的治疗和随访,个人可以达到持续长期的缓解。本文主要针对阿片类药物使用障碍的临床管理提出指导建议,内容涉及一线和二线治疗方案,替代治疗以及辅助治疗方案,降低危害策略。 </P> <P> </P>拓展指南:<STRONG>与<FONT color=red>阿片</FONT>相关指南:</STRONG><BR> <UL> <LI><A title="2017 共识建议:接受阿片类药物治疗的慢性疼痛患者合理的尿液药物监测" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=9259e1c00153039e">2017 共识建议:接受阿片类药物治疗的慢性疼痛患者合理的尿液药物监测</A> <LI><A title="2017 加拿大应用阿片类药物治疗慢性非癌性疼痛指南" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=1b0881c001a33224">2017 加拿大应用阿片类药物治疗慢性非癌性疼痛指南</A> <LI><A title="2016 CPSBC阿片类药物滥用指南:美沙酮和丁丙诺啡" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=3a6f91c001a1944c">2016 CPSBC阿片类药物滥用指南:美沙酮和丁丙诺啡</A> <LI><A title=【精华指南】驾驭癌性疼痛,权衡阿片药物剂量,医生无需纠结 target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=0540b1c001388ed1">【精华指南】驾驭癌性疼痛,权衡阿片药物剂量,医生无需纠结</A> <LI><A title="2017 拉丁美洲指南:阿片类药物治疗慢性非癌性疼痛" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=2b5f21c0013e65a4">2017 拉丁美洲指南:阿片类药物治疗慢性非癌性疼痛</A> 更多信息请点击:<A target=_blank href="http://www.medsci.cn/guideline/list.do?q=%E9%98%BF%E7%89%87">有关阿片更多指南</A></LI></UL>, tagList=[TagDto(tagId=9680, tagName=阿片类药物), TagDto(tagId=71472, tagName=药物使用障碍)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5792, appHits=86, showAppHits=0, pcHits=4767, showPcHits=1377, likes=142, shares=1, comments=8, approvalStatus=1, publishedTime=Sun Mar 11 22:15:42 CST 2018, publishedTimeString=2018-03-05, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Mar 11 22:15:42 CST 2018, updatedBy=null, updatedName=null, updatedTime=Wed Jan 03 17:42:20 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 加拿大临床实践指南:阿片类药物使用障碍的管理)])
2018 加拿大临床实践指南:阿片类药物使用障碍的管理
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=295805, encodeId=dff5295805f9, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/13/c36860368f59b7f042bac242c6785040.jpg, createdBy=457b1858657, createdName=ms2296823935859672, createdTime=Tue Mar 13 10:56:21 CST 2018, time=2018-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295463, encodeId=bd3c295463f5, content=厉害了我的哥, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Mon Mar 12 08:18:21 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295418, encodeId=283929541809, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Mar 12 07:12:56 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295330, encodeId=c16d2953305d, content=学习学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Mon Mar 12 00:05:59 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295307, encodeId=f2d729530ec8, content=**类药物使用障碍通常是一种慢性.复发的疾病状态.其发病率和死亡率逐渐增加.然而,随着适当的治疗和随访.个人可以达到持续长期的缓解.本文主要针对**类药物使用障碍的临床管理提出指导建议.内容涉及一线和二线治疗方案.替代治疗以及辅助治疗方案.降低危害策略., beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sun Mar 11 23:08:11 CST 2018, time=2018-03-11, status=1, ipAttribution=)]
    2018-03-13 ms2296823935859672

    学习了.谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=295805, encodeId=dff5295805f9, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/13/c36860368f59b7f042bac242c6785040.jpg, createdBy=457b1858657, createdName=ms2296823935859672, createdTime=Tue Mar 13 10:56:21 CST 2018, time=2018-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295463, encodeId=bd3c295463f5, content=厉害了我的哥, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Mon Mar 12 08:18:21 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295418, encodeId=283929541809, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Mar 12 07:12:56 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295330, encodeId=c16d2953305d, content=学习学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Mon Mar 12 00:05:59 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295307, encodeId=f2d729530ec8, content=**类药物使用障碍通常是一种慢性.复发的疾病状态.其发病率和死亡率逐渐增加.然而,随着适当的治疗和随访.个人可以达到持续长期的缓解.本文主要针对**类药物使用障碍的临床管理提出指导建议.内容涉及一线和二线治疗方案.替代治疗以及辅助治疗方案.降低危害策略., beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sun Mar 11 23:08:11 CST 2018, time=2018-03-11, status=1, ipAttribution=)]
    2018-03-12 飛歌

    厉害了我的哥

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=295805, encodeId=dff5295805f9, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/13/c36860368f59b7f042bac242c6785040.jpg, createdBy=457b1858657, createdName=ms2296823935859672, createdTime=Tue Mar 13 10:56:21 CST 2018, time=2018-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295463, encodeId=bd3c295463f5, content=厉害了我的哥, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Mon Mar 12 08:18:21 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295418, encodeId=283929541809, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Mar 12 07:12:56 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295330, encodeId=c16d2953305d, content=学习学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Mon Mar 12 00:05:59 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295307, encodeId=f2d729530ec8, content=**类药物使用障碍通常是一种慢性.复发的疾病状态.其发病率和死亡率逐渐增加.然而,随着适当的治疗和随访.个人可以达到持续长期的缓解.本文主要针对**类药物使用障碍的临床管理提出指导建议.内容涉及一线和二线治疗方案.替代治疗以及辅助治疗方案.降低危害策略., beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sun Mar 11 23:08:11 CST 2018, time=2018-03-11, status=1, ipAttribution=)]
    2018-03-12 131****1460

    学习了受益匪浅

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=295805, encodeId=dff5295805f9, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/13/c36860368f59b7f042bac242c6785040.jpg, createdBy=457b1858657, createdName=ms2296823935859672, createdTime=Tue Mar 13 10:56:21 CST 2018, time=2018-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295463, encodeId=bd3c295463f5, content=厉害了我的哥, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Mon Mar 12 08:18:21 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295418, encodeId=283929541809, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Mar 12 07:12:56 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295330, encodeId=c16d2953305d, content=学习学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Mon Mar 12 00:05:59 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295307, encodeId=f2d729530ec8, content=**类药物使用障碍通常是一种慢性.复发的疾病状态.其发病率和死亡率逐渐增加.然而,随着适当的治疗和随访.个人可以达到持续长期的缓解.本文主要针对**类药物使用障碍的临床管理提出指导建议.内容涉及一线和二线治疗方案.替代治疗以及辅助治疗方案.降低危害策略., beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sun Mar 11 23:08:11 CST 2018, time=2018-03-11, status=1, ipAttribution=)]
    2018-03-12 jihuaijun1112

    学习学习学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=295805, encodeId=dff5295805f9, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/13/c36860368f59b7f042bac242c6785040.jpg, createdBy=457b1858657, createdName=ms2296823935859672, createdTime=Tue Mar 13 10:56:21 CST 2018, time=2018-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295463, encodeId=bd3c295463f5, content=厉害了我的哥, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Mon Mar 12 08:18:21 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295418, encodeId=283929541809, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Mar 12 07:12:56 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295330, encodeId=c16d2953305d, content=学习学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Mon Mar 12 00:05:59 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295307, encodeId=f2d729530ec8, content=**类药物使用障碍通常是一种慢性.复发的疾病状态.其发病率和死亡率逐渐增加.然而,随着适当的治疗和随访.个人可以达到持续长期的缓解.本文主要针对**类药物使用障碍的临床管理提出指导建议.内容涉及一线和二线治疗方案.替代治疗以及辅助治疗方案.降低危害策略., beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sun Mar 11 23:08:11 CST 2018, time=2018-03-11, status=1, ipAttribution=)]
    2018-03-11 有备才能无患

    **类药物使用障碍通常是一种慢性.复发的疾病状态.其发病率和死亡率逐渐增加.然而,随着适当的治疗和随访.个人可以达到持续长期的缓解.本文主要针对**类药物使用障碍的临床管理提出指导建议.内容涉及一线和二线治疗方案.替代治疗以及辅助治疗方案.降低危害策略.

    0